<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2022-8-2-0-7</article-id><article-id pub-id-type="publisher-id">2746</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Correlation of Biochemical Abnormalities with the Severity of Hospitalized Covid-19 Patients&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Correlation of Biochemical Abnormalities with the Severity of Hospitalized Covid-19 Patients&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Silambanan</surname><given-names>Santhi</given-names></name><name xml:lang="en"><surname>Silambanan</surname><given-names>Santhi</given-names></name></name-alternatives><email>santhisilambanan@sriramachandra.edu.in</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Koshy</surname><given-names>Teena</given-names></name><name xml:lang="en"><surname>Koshy</surname><given-names>Teena</given-names></name></name-alternatives><email>teenak@sriramachandra.edu.in</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>K. K</surname><given-names>Mahesh</given-names></name><name xml:lang="en"><surname>K. K</surname><given-names>Mahesh</given-names></name></name-alternatives><email>doctor.mahesh1985@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ch. A</surname><given-names>Jasmine</given-names></name><name xml:lang="en"><surname>Ch. A</surname><given-names>Jasmine</given-names></name></name-alternatives><email>jasminechandra96@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Bhaskar</surname><given-names>Emmanuel</given-names></name><name xml:lang="en"><surname>Bhaskar</surname><given-names>Emmanuel</given-names></name></name-alternatives><email>drebhaskar@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Moorthy</surname><given-names>Swathy</given-names></name><name xml:lang="en"><surname>Moorthy</surname><given-names>Swathy</given-names></name></name-alternatives><email>drswathymoorthy@sriramachandra.edu.in</email></contrib></contrib-group><pub-date pub-type="epub"><year>2022</year></pub-date><volume>8</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2022/2/Биомедицинские_исследования_июнь_2022-89-101.pdf" /><abstract xml:lang="ru"><p>Background:&amp;nbsp;Coronavirus Disease-19 (COVID-19) has a global impact. The laboratory assessments in Covid-19 illness help in better understanding the disease pathophysiology useful in screening asymptomatic individuals to diagnosis, prognosis and monitoring the affected patients. The aim of the study:&amp;nbsp;To observe the association between biochemical and inflammatory parameters among the hospitalised COVID-19 patients of different clinical severity. Materials and methods:&amp;nbsp;This was a retrospective study carried out with the approval of the Institutional Ethics Committee. The study included patients over 18 years, hospitalised with COVID-19 infection, grouped into three severity groups, admitted to ward, high dependency unit or intensive care unit between May to September 2020.&amp;nbsp;Data collection was carried out by manual perusal of inpatient case sheets, computerised patient data system and transcription database for discharge summaries. The biochemical and inflammatory markers like plasma glucose, renal function tests, serum electrolytes, liver function tests, erythrocyte sedimentation rate (ESR), C-Reactive protein (CRP), d-dimer, ferritin, Lactate dehydrogenase (LDH) at the time of admission were collected. Data was expressed as mean and standard deviation or median and range. ANOVA test followed by post hoc (Tukey) test, Pearson correlation and Receiver Operating Characteristics (ROC) Curve analysis were performed. Results:&amp;nbsp;Significant correlations were observed between the mild and moderate-severe illness groups with respect to fasting plasma glucose, blood urea nitrogen, creatinine, direct bilirubin, total protein, albumin, ferritin and LDH. The AUC was the highest for LDH at 0.64 followed by blood urea nitrogen to creatinine ratio at 0.62. Conclusion:&amp;nbsp;High levels of renal function parameters were potential predictors of acute kidney injury among patients with COVID-19. Fasting plasma glucose, serum albumin, LDH, Blood urea nitrogen (BUN) and BUN-creatinine ratio are better indicators of the severity of the disease with multiorgan dysfunction.</p></abstract><trans-abstract xml:lang="en"><p>Background:&amp;nbsp;Coronavirus Disease-19 (COVID-19) has a global impact. The laboratory assessments in Covid-19 illness help in better understanding the disease pathophysiology useful in screening asymptomatic individuals to diagnosis, prognosis and monitoring the affected patients. The aim of the study:&amp;nbsp;To observe the association between biochemical and inflammatory parameters among the hospitalised COVID-19 patients of different clinical severity. Materials and methods:&amp;nbsp;This was a retrospective study carried out with the approval of the Institutional Ethics Committee. The study included patients over 18 years, hospitalised with COVID-19 infection, grouped into three severity groups, admitted to ward, high dependency unit or intensive care unit between May to September 2020.&amp;nbsp;Data collection was carried out by manual perusal of inpatient case sheets, computerised patient data system and transcription database for discharge summaries. The biochemical and inflammatory markers like plasma glucose, renal function tests, serum electrolytes, liver function tests, erythrocyte sedimentation rate (ESR), C-Reactive protein (CRP), d-dimer, ferritin, Lactate dehydrogenase (LDH) at the time of admission were collected. Data was expressed as mean and standard deviation or median and range. ANOVA test followed by post hoc (Tukey) test, Pearson correlation and Receiver Operating Characteristics (ROC) Curve analysis were performed. Results:&amp;nbsp;Significant correlations were observed between the mild and moderate-severe illness groups with respect to fasting plasma glucose, blood urea nitrogen, creatinine, direct bilirubin, total protein, albumin, ferritin and LDH. The AUC was the highest for LDH at 0.64 followed by blood urea nitrogen to creatinine ratio at 0.62. Conclusion:&amp;nbsp;High levels of renal function parameters were potential predictors of acute kidney injury among patients with COVID-19. Fasting plasma glucose, serum albumin, LDH, Blood urea nitrogen (BUN) and BUN-creatinine ratio are better indicators of the severity of the disease with multiorgan dysfunction.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>SARS-CoV2</kwd><kwd>acute kidney injury</kwd><kwd>liver impairment</kwd><kwd>ferritin</kwd><kwd>angiotensin converting enzyme 2</kwd><kwd>electrolyte alteration</kwd><kwd>lactate dehydrogenase</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>SARS-CoV2</kwd><kwd>acute kidney injury</kwd><kwd>liver impairment</kwd><kwd>ferritin</kwd><kwd>angiotensin converting enzyme 2</kwd><kwd>electrolyte alteration</kwd><kwd>lactate dehydrogenase</kwd></kwd-group></article-meta></front><back><ack><p>The authors wish to thank the participants who have provided the data for conducting the study and publication of this article. The authors wish to thank the management for providing the necessary infrastructure and support for conducting the study and publication of the article.</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science. 2020;12:8. DOI: https://doi.org/10.1038/s41368-020-0074-x</mixed-citation></ref><ref id="B2"><mixed-citation>Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. [cited 2021 Nov 21]. Available from: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19).</mixed-citation></ref><ref id="B3"><mixed-citation>Liu J, Liu Y, Xiang P, et al. Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage. Journal of Translational Medicine. 2020;18(1):206. DOI: https://doi.org/10.1186/s12967-020-02374-0</mixed-citation></ref><ref id="B4"><mixed-citation>Big data on Covid-19 around the world [Internet]. China Daily Network. 2020 [cited 2021 Nov 21]. Available from: https://www.chinadaily.com.cn/china/special_coverage/2020latestdata.</mixed-citation></ref><ref id="B5"><mixed-citation>Team NCPERE. The epidemiological characteristics of an outbreak of 2019 novel corona diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51. DOI: https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003</mixed-citation></ref><ref id="B6"><mixed-citation>Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalised patients with 2019 novel corona virus- infected pneumonia in Wuhan, China. Journal of the American Medical Association. 2020;323(11):1061-1069. DOI: https://doi.org/10.1001/jama.2020.1585</mixed-citation></ref><ref id="B7"><mixed-citation>Wang D, Li R, Wang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infectious Diseases. 2020;20:519. DOI: https://doi.org/10.1186/s12879-020-05242-w</mixed-citation></ref><ref id="B8"><mixed-citation>Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of theAcute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Medicine. 2020;46:654-672. DOI: https://doi.org/10.1007/s00134-019-05869-7</mixed-citation></ref><ref id="B9"><mixed-citation>Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. 2020;97(5):829-838. DOI: https://doi.org/10.1016/j.kint.2020.03.005</mixed-citation></ref><ref id="B10"><mixed-citation>Durvasula R, Wellington T, McNamara E, et al. COVID-19 and kidney failure in the acute care setting: our experience from Seattle. American Journal of Kidney Diseases. 2020;76:4-6. DOI: https://doi.org/10.1053/j.ajkd.2020.04.001</mixed-citation></ref><ref id="B11"><mixed-citation>South AM, Diz DI, Chapell MC. COVID-19, ACE2 and the cardiovascular consequences. American Journal of Physiology - Heart and Circulatory Physiology. 2020;318(5):H1084-90. DOI: https://doi.org/10.1152/ajpheart.00217.2020</mixed-citation></ref><ref id="B12"><mixed-citation>Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Annals of Clinical Biochemistry. 2020;57(3). https://doi.org/10.1177/0004563220922255</mixed-citation></ref><ref id="B13"><mixed-citation>Samavati S, Uhal BD. ACE2, Much More Than Just a Receptor for SARS-COV-2. Frontiers in Cellular and Infection Microbiology. 2020;10:317. DOI: https://doi.org/10.3389/fcimb.2020.00317</mixed-citation></ref><ref id="B14"><mixed-citation>Chen D, Li X, Song Q, et al. Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19) [Internet]. medRxiv. 2020 [cited 2021 Nov 21]. DOI: https://doi.org/10.1101/2020.02.27.20028530. Available from: https://www.medrxiv.org/content/10.1101/2020.02.27.20028530v1.full.pdf</mixed-citation></ref><ref id="B15"><mixed-citation>Pan L, Mu MI, Yang P, et al. clinical characteristics of COVID-19 patientswith digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicentric study. American Journal of Gastroenterology. 2020;115:766-73. DOI: https://doi.org/10.14309/ajg.0000000000000620</mixed-citation></ref><ref id="B16"><mixed-citation>Oussalah A, Gleye S, Urmes IC, et al. the spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. EClinicalMedicine. 2020;27:100554. DOI: https://doi.org/10.1016/j.eclinm.2020.100554</mixed-citation></ref><ref id="B17"><mixed-citation>Uhlen M, Fagerberg L, Hallstorm BM, et al. Tissue based map of the human proteome. Science. 2015;347(6220):1260419. DOI: https://doi.org/10.1126/science.1260419</mixed-citation></ref><ref id="B18"><mixed-citation>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020;8(4):420-422. DOI: https://doi.org/10.1016/S2213-2600(20)30076-X</mixed-citation></ref><ref id="B19"><mixed-citation>Feng G, Zheng KI, Yan QQ, et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. Journal of Clinical and Translational Hepatology. 2020;8(1):18-24. DOI: https://doi.org/10.14218/JCTH.2020.00018</mixed-citation></ref><ref id="B20"><mixed-citation>Yazar H, Kayacan Y, Ozdin M. De Ritis ratio and biochemical parameters in COVID-19 patients. Archives of Physiology and Biochemistry. 2020;6. DOI: https://doi.org/10.1080/13813455.2020.1788604</mixed-citation></ref><ref id="B21"><mixed-citation>Zinellu A, Arru F, De Vito A, et al. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients. European Journal of Clinical Investigation. 2021;51(1):e13427. DOI: https://doi.org/10.1111/eci.13427</mixed-citation></ref><ref id="B22"><mixed-citation>Varim C, Yaylac S, Demirci T, et al. Neutrophil count to albumin ratio as a new predictor of mortality in patients with COVID-19 Infection. Revista da Associacao Medica Brasileira. 2020;66(2):77-81. DOI: https://doi.org/10.1590/1806-9282.66.S2.77</mixed-citation></ref><ref id="B23"><mixed-citation>Lippi G, Plebani M. the critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clinical Chemistry and Laboratory Medicine. 2020;58(7):1063-9. DOI: https://doi.org/10.1515/cclm-2020-0240</mixed-citation></ref><ref id="B24"><mixed-citation>Chen T, Wu DI, Chen H, et al. clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. DOI: https://doi.org/10.1136/bmj.m1091</mixed-citation></ref><ref id="B25"><mixed-citation>Qui H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious Diseases. 2020;20(6):689-696. DOI: https://doi.org/10.1016/S1473-3099(20)30198-5</mixed-citation></ref><ref id="B26"><mixed-citation>Toutkaboni MP, Askari E, Khalili N, et al.&amp;nbsp; Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes and New Infections. 2020;38:100777. DOI: https://doi.org/10.1016/j.nmni.2020.100777</mixed-citation></ref><ref id="B27"><mixed-citation>Thompson S, Bohn MK, Mancini N, et al. IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients. Clinical Chemistry and Laboratory Medicine. 2020;58(12):2009-2016. DOI: https://doi.org/10.1515/cclm-2020-1414</mixed-citation></ref><ref id="B28"><mixed-citation>Danwang C, Endomba FT, Nkeck JR, et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomarker Research. 2020;8:37. DOI: https://doi.org/10.1186/s40364-020-00217-0</mixed-citation></ref><ref id="B29"><mixed-citation>Satish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta analysis. Diabetes, Obesity and Metabolism. 2021;23(3):870-874. DOI: https://dx.doi.org/10.1111/dom.14269</mixed-citation></ref><ref id="B30"><mixed-citation>Wang A, Zhao W, Xu Z, et al. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Research and Clinical Practice. 2020;162:108118. DOI: https://doi.org/10.1016/j.diabres.2020.108118</mixed-citation></ref><ref id="B31"><mixed-citation>Satish T, Tapp RJ, Cooper ME, et al. Potential metabolic and inflammatory pathways between COVID-19 and new onset diabetes. Diabetes and Metabolism. 2021;47(2):101204. DOI: https://doi.org/10.1016/j.diabet.2020.10.002</mixed-citation></ref></ref-list></back></article>